1. Home
  2. SXT vs PTCT Comparison

SXT vs PTCT Comparison

Compare SXT & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensient Technologies Corporation

SXT

Sensient Technologies Corporation

SELL

Current Price

$134.02

Market Cap

5.5B

Sector

Industrials

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$59.27

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SXT
PTCT
Founded
1882
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.5B
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
SXT
PTCT
Price
$134.02
$59.27
Analyst Decision
Buy
Buy
Analyst Count
5
15
Target Price
★ $144.40
$100.33
AVG Volume (30 Days)
303.4K
★ 1.2M
Earning Date
10-30-2026
10-29-2026
Dividend Yield
★ 1.23%
N/A
EPS Growth
7.48
★ 264.48
EPS
★ 2.24
0.90
Revenue
★ $1,396,499,000.00
$264,734,000.00
Revenue This Year
$11.85
N/A
Revenue Next Year
$13.72
$9.47
P/E Ratio
★ $59.44
$67.73
Revenue Growth
N/A
★ 36.19
52 Week Low
$82.60
$58.80
52 Week High
$138.82
$90.87

Technical Indicators

Market Signals
Indicator
SXT
PTCT
Relative Strength Index (RSI) 59.57 34.70
Support Level $131.37 N/A
Resistance Level $137.17 $68.93
Average True Range (ATR) 3.27 1.93
MACD 0.42 -0.15
Stochastic Oscillator 68.91 13.82

Price Performance

Historical Comparison
SXT
PTCT

About SXT Sensient Technologies Corporation

Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: